Launch & commercialization

With the largest installed base of over 10,000 BenchMark IHC/ISH staining platforms worldwide, and a powerful affiliate network in 100+ countries, our partners have the broadest access to patients.

cancer strain

CASE STUDY  

Bridging the path to CDx success

Find out how we enabled significant access to personalized therapy for cancer patients.

 

DISCOVER MORE  >

Our commercial strength is unrivaled